SCIENTIFIC ADVISOR

• Ex-head of the Global Fund, the world's largest financier of AIDS, TB, and malaria prevention, treatment, and care programs, from 2012-2017

• United States Global AIDS Coordinator 2006-2009 under G.W. Bush administration

• Board member: Clinton Health Access Initiative, IAVI, Big Win Philanthropy, the Elton John AIDS Foundation, Global Health Corps, and Enochian Biosciences

• Professor of Medicine at Georgetown University

SCIENTIFIC ADVISOR

• Vice Provost for Global Initiatives at the University of Pennsylvania and chair of the Department of Medical Ethics and Health Policy

• One of the 16 members of the President Biden COVID-19 Advisory Board

• Senior Fellow at the Center for American Progress

• Oncologist, bioethicist; ex-Harvard Medical School and ex-National Institutes of Health

SCIENTIFIC ADVISOR

• Chief Executive Officer at Platform Life Sciences Inc. and the Principal Investigator of multiple adaptive platform trials, including the Covid-19 TOGETHER trial

• Professor at McMaster University in the Department of Health Research Methods, Impact, and Evaluation as well as the University of Rwanda, School of Public Health. He is a Senior Scientist at VirX@Stanford

• Dr. Mills has published more than 550 peer reviewed papers

SCIENTIFIC ADVISOR

• Co-founder and Chief Medical Officer of RHTM, a Y-Combinator backed technology company building solutions for patients with infection-associated chronic illness.

• Physician and post-viral illness expert specializing in myalgic encephalomyelitis (ME/CFS) and its comorbidities.

• Member of the ME/CFS Clinician Coalition and co-authored the official clinical guidance for ME/CFS.

• Dr. Curtin has a personal understanding of the difficulties Long Covid patients experience as she is a mostly recovered ME/CFS patient herself.

SCIENTIFIC ADVISOR

• Associate Professor of Medicine at the University of Pittsburgh.

• Infectious diseases specialist with a focus on improving the public health outcomes of people infected with HIV/AIDS.

• Member of the African Academy of Sciences

SCIENTIFIC ADVISOR

• Professor of Medicine in Residence at the University of California, San Francisco (UCSF).

• Faculty member in the Division of HIV, Infectious Diseases and Global Medicine at Zuckerberg San Francisco General Hospital.

• Internationally recognized expert on HIV pathogenesis and treatment, now leading a large program focused on the pathogenesis and treatment of Long COVID. Dr. Deeks has published over 650 peer-review articles.

• Based on a recent study conducted at Stanford, he is among the top 0.01% of all scientists, based on citations.

SCIENTIFIC ADVISOR

• Professor of Primary Care at Oxford University, where he leads the Infections and Acute Care Research Group.

• Co-Chief Investigator of the PRINCIPLE and PANORAMIC adaptive, platform, randomised, controlled trials of community treatments for COVID 19, that have recruited >38,000 participants and evaluated 9 medicines so far.

• Published >500 papers and led or helped lead ~30 randomised clinical trials, and recently published trial results in the world’s top three general medical journals.

SCIENTIFIC ADVISOR

• SVP Drug Development Science, Integrated Drug Development at Certara Inc.

• 28 years experience within pharmaceutical development, with all phases of drug development including interactions with regulatory authorities during both the development and registration processes.

• Broad knowledge of drug discovery and development principles and practice with special focus on risks associated with early projects.

SCIENTIFIC ADVISOR

• Professor at the University of the Witwatersrand, Johannesburg.

• His work involves health systems research that directly translates into national programmes, most recently involving the antiretrovirals, dolutegravir, tenofovir alafenamide, cabotegravir, and doravirine.

• For over 20 years he has been an advisor to bodies such as the South African government, UNAIDS, and WHO, contributing to international, regional, and national HIV guidelines.

SCIENTIFIC ADVISOR

• Assistant Professor of Medicine at UCSF.

• Infectious disease clinical-translational physician-scientist focused on HIV and COVID-19.

• Involved with clinical and laboratory research aimed at understanding the HIV reservoir and implementing clinical trials to disrupt the reservoir with the aim of inducing antiretroviral therapy-free HIV remission.

• Highly active Long Covid researcher, leading an ongoing study of a large patient cohort.

EXECUTIVE DIRECTOR

• Ex-technology founder, backed by Goldman Sachs and J.P. Morgan

• Ex-corporate finance at J.P. Morgan and others

• Graduate of Oxford

DIRECTOR

• Technology founder, backed by Google Ventures

• Ex-product manager, Google

• Graduate of UCL

DIRECTOR

• Medical doctor at NHS England

• Graduate of University of Leeds

ADVOCATE

• Assistant Professor of Machine Learning at University of Toronto

• Senior Research Scientist at Deep Mind

• Graduate of Oxford and University of Toronto

ADVOCATE

• AI/ML researcher

• Director of Scientific Operations at longevity co

• Graduate of Dartmouth

ADVOCATE

• Technology founder at Ping Things, backed by GE Ventures

• Ex-senior scientist at Johns Hopkins University Applied Physics Laboratory

• Graduate of Oxford, Johns Hopkins, University of Maryland

TRIALS ADVISORY COMMITTEE

• Ex-community manager at Effective Altruism

• Graduate of University of Groningen

ADVOCATE

• Technology founder at Lief Therapeutics

• Ex-neuroscience researcher at Harvard and Stanford

• Graduate of Northwestern